Antonio Giordano, Md

This study tests whether adding the experimental drug onvansertib to standard chemotherapy (paclitaxel) is safe and effective for people with triple-negative breast cancer that has spread or cannot be removed by surgery. About 50 adults with this aggressive cancer type will recei…